CarieScan expands its distribution network (1958J)

TIDM3DD

RNS Number : 1958J

3D Diagnostic Imaging PLC

27 June 2011

 
 For Immediate Release   27 June 2011

3D DIAGNOSTIC IMAGING PLC

("3D" or "the Company")

CarieScan expands its distribution network within Europe

3D is pleased to announce that its subsidiary CarieScan Limited ("CarieScan"), the producer of a handheld device for the early detection and monitoring of tooth decay, has appointed Arseus Dental as its exclusive distributor of the CarieScan PRO(tm) within Belgium, the Netherlands and Luxembourg ("Benelux"), where there are believed to be more than 17,000 dental practitioners.

Arseus Dental, a division of NYSE Euronext Brussels-listed Arseus NV, is a leading European supplier of added-value products and services to dental laboratories and other professionals in the dental sector. Arseus Dental also has a production facility in Switzerland which manufactures precision components for the dental industry.

With the signing of this agreement CarieScan now has distribution partners in 11 key territories and continues to strengthen its distribution network across mainland Europe and the rest of the world. It is anticipated that the initial stocking order for the Benelux region will be shipped this month.

Commenting on this agreement, Graham Lay, Chief Executive Officer of 3D Diagnostic Imaging, said:

"This agreement marks a welcome expansion of our business into continental Europe, which is an important area for our growth. We are delighted to have such a prominent partner as Arseus Dental in the region as they are recognised by dental healthcare professionals as both a qualitative and competitive supplier. We are continuing discussions with other potential distribution partners across the world and hope to be in a position to make further announcements in due course."

Louis van der Mortel, General Manager of Arseus Dental commented:

"The CarieScan PRO(TM) is an excellent addition to the Arseus Dental product offering. It broadens our portfolio of the most innovative dental technologies and enables us to offer leading edge dental care to our customer base. We are certain that the CarieScan PRO(TM) will be well received by both patients and clinicians as more preventive treatment programmes are demanded in the Benelux."

ENDS

For further information please contact:

 
 3D Diagnostic Imaging Plc     +44 (0) 1624 679000 
 Graham Lay, CEO 
 Oliver Cooke, FD 
 
 finnCap                       NOMAD & Broker 
 Geoff Nash                    +44 (0)20 7600 1658 
 Henrik Persson 
 Stephen Norcross (broking) 
 
 Buchanan Communications       +44 (0) 131 226 4427 
 Diane Stewart                 +44 (0) 207 466 5000 
 Carrie Clement

Notes to Editors:

3D owns the protected rights to a technology platform with a number of significant potential commercial applications. Its first product to market is the CarieScan PRO(TM).

The CarieScan PRO(TM) measures the presence of tooth decay earlier and more accurately than any other device on the market and is more than 90% accurate in detecting both sound and carious teeth, well ahead of other methods. It detects "hidden" decay, providing dental practitioners with the opportunity to arrest or even reverse decay, driving the trend towards preventative dental care.

The lightweight CarieScan PRO(TM) detection monitor not only offers best-in-class performance for decay detection but also allows easy monitoring of the effect of treatment regimes to show decay advancement or regression, thus enabling dentists to tailor treatment to the needs of the patient at a low cost. The CarieScan PROtm consists of a hand piece and a disposable sensor which is held against the tooth being examined in a process which takes approximately 4 seconds per tooth with the result displayed on the CarieScan PRO(TM).

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCDKODBQBKDOAB

3D Diagnostic (LSE:3DD)
Historical Stock Chart
From May 2024 to Jun 2024